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Lack of cross-protection against Mycoplasma
haemofelis infection and signs of enhancement
in “Candidatus Mycoplasma turicensis”-recovered
cats
Julia Baumann1,2, Marilisa Novacco1,2, Barbara Willi1,3, Barbara Riond1, Marina L Meli1,2, Felicitas S Boretti3
and Regina Hofmann-Lehmann1,2*
Abstract
“Mycoplasma haemofelis” and “Candidatus Mycoplasma turicensis” are feline hemoplasmas that induce hemolytic
anemia. Protection from homologous re-challenge was recently demonstrated in cats recovered from primary
infection. Here, we determined if cats recovered from “Cand. M. turicensis” infection were protected against
infections with the more pathogenic M. haemofelis. Ten specified pathogen-free cats were exposed to M.
haemofelis. Five of the ten cats had recovered from “Cand. M. turicensis” bacteremia (group A), and five cats were
naïve controls (group B). No cross-protection was observed. By contrast, the “Cand. M. turicensis”-recovered cats
displayed faster M. haemofelis infection onset (earlier PCR-positive and anemic) than the controls. No “Cand. M.
turicensis” was detected in any cat. M. haemofelis shedding was observed in saliva, feces and urine. In both groups,
evidence of a Th1 response was observed (high IFN-γ, low IL-4), but IL-10 levels were also high. In group A, total,
CD4+ and CD8+ T cells increased within days after M. haemofelis exposure. At times of maximal bacteremia,
macrocytic hypochromic anemia, neutropenia, monocytosis and a decrease in leukocyte, eosinophil, and
lymphocyte counts and subsets thereof (B- and T-cells, CD4+, CD8+ and CD4+CD25+ cells) were particularly
significant in group A. Moreover, an increase in protein concentrations, hypoalbuminemia and a polyclonal
hypergammaglobulinemia were observed. Five of ten M. haemofelis-infected cats subsequently cleared bacteremia
without antibiotic treatment. In conclusion, the study suggests that a previous hemoplasma infection, even when
the cat has ostensibly recovered, may influence subsequent infections, lead to an enhancement phenomenon and
other differences in infection kinetics.
Introduction
Hemotropic mycoplasmas (hemoplasmas) are cell-wall
free bacteria that attach to red blood cells and poten-
tially induce hemolytic anemia [1]. In the domestic cat,
at least three feline hemotropic mycoplasma species are
known: Mycoplasma haemofelis (M. haemofelis), “Candi-
datus Mycoplasma haemominutum” (“Cand. M. haemo-
minutum”) and “Candidatus Mycoplasma turicensis”
(“Cand. M. turicensis”) [2–5]. The pathogenic potential
significantly varies among the three feline species; M.
haemofelis is the most pathogenic of the three species,
and an acute infection often results in hemolytic
anemia [1,6].
The diagnosis of feline hemotropic mycoplasma infec-
tion relies on the detection and differentiation of the
infectious agents by sensitive and specific polymerase
chain reaction (PCR) [2,7]. To quantify the humoral im-
mune response to feline hemoplasmas, enzyme-linked
immunosorbent assays (ELISA) based on a recombinant
M. haemofelis DnaK protein have been developed [8,9].
The recombinant M. haemofelis protein recognizes
antibodies to M. haemofelis and, to a lesser degree,
antibodies to “Cand. M. turicensis” and “Cand. M.
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haemominutum”; the observed cross-reactivity of the
humoral immune response led to the assumption of a
potential cross-protection among the three hemoplasma
infections. In a recent study, high levels of antibodies
were detected in cats experimentally infected with
“Cand. M. turicensis”, even months after the infection
and bacteremia had cleared [10]. These “Cand. M. turi-
censis” PCR-negative seropositive cats were also pro-
tected from subsequent “Cand. M. turicensis” challenge
[10,11]. Similarly, cats that had overcome M. haemofelis
bacteremia and were PCR-negative and serologically
positive for M. haemofelis were subsequently protected
from a second M. haemofelis bacteremia after re-
exposure [12]. Limited information is available concern-
ing potential cross-protection against infections with
different feline hemoplasma species. In some naturally
infected cats and wildcats, dual or triple infections with
M. haemofelis, “Cand. M. haemominutum” and “Cand.
M. turicensis” have been reported [13–16]. However, in
natural infections, it typically cannot be determined if
the infections were simultaneously or sequentially ac-
quired. Cross-protection might be expected only when
the infections are sequentially acquired after an efficient
immune response had been raised. Experimental co-
infection was demonstrated in an early infection study
using so-called large and small Haemobartonella felis
strains [17]. However, these cats had not cleared the
primary infection when superinfected with a second
hemoplasma strain, and thus no cross-protection was
observed [17].
A vaccination approach involving attenuated organ-
isms may offer hemoplasma protection [12]. “Cand. M.
turicensis” is much less pathogenic than M. haemofelis
[2], and thus “Cand. M. turicensis” would be an ideal
candidate for an attenuated M. haemofelis vaccine, if
cross-protection against M. haemofelis exposure was
found in cats that developed immunity against “Cand.
M. turicensis”.
Thus, the aim of the present study was to investigate
potential cross-protection against M. haemofelis in cats
that had overcome a previous “Cand. M. turicensis” in-
fection and to characterize the course of infection in
naïve and “Cand. M. turicensis”-recovered cats, by ana-
lyzing hematological and clinical chemistry parameters,
lymphocyte subsets, cytokine transcription levels and
hemoplasma shedding patterns.
Materials and methods
Animals and experimental design
Ten adult male specified pathogen-free (SPF) cats (Liberty
Research, Waverly, NY, USA) were included in the present
study. The cats were assigned to two groups: group A
comprised five cats (FIA1, FIA2, FHT1, FHX4, and FHX5)
that had previously experienced experimental “Cand. M.
turicensis” low-dose infection described in detail else-
where [18], and group B comprised five naïve SPF cats
(KCY2, ZKA2, AKL4, JCT2, and KCU1) [19]. The cats in
group A were listed in the previous study as A1, A2, T1,
X4 and X5 [18]. Prior to the start of this experiment, the
cats in group A had overcome acute “Cand. M. turicensis”
infection and bacteremia and were PCR-negative and
serologically positive (for detailed description of the PCR
and serology see below). All cats in group A were five
years old, whereas in group B, three cats were three years
old (KCY2, JCT2, and KCU1), and two cats were six years
old (ZKA2 and AKL4). All cats had been castrated prior
to this experiment.
All experiments were performed according to Swiss
law and were officially approved by the veterinary office
of the canton of Zurich (TVB 159/2010). The cats were
kept in two separate groups in a confined university
facility under barrier conditions and optimal ethological
and hygienic conditions as previously described [20].
Prior to the start of the experiment, each cat was clinic-
ally examined, and the SPF status of the cats was veri-
fied by testing for absence of infections with feline
hemoplasmas, parvovirus, calicivirus, coronavirus,
herpesvirus-1, leukemia and immunodeficiency virus,
Bartonella henselae and Chlamydophila felis using
sampling procedures and methods as previously
described [21].
All cats were subjected to low-dose M. haemofelis
exposure on day 0 as previously described [19] (for
details see below). EDTA-anticoagulated blood and
serum samples were collected for PCR, hematology,
clinical chemistry and serology analyses before (at day
0) and after M. haemofelis exposure (for time points
see Figure 1 and Additional file 1). To monitor M.
haemofelis shedding, saliva and rectal swabs were col-
lected at the time points indicated in Figure 1 and on
days 141, 232 and 286 using commercially available
cotton swabs as previously described [22]. Urine sam-
ples were collected from all cats by cystocentesis at
one day prior to and on days 57 and 104 after M.
haemofelis exposure and on day 28 from the cats in
group A. Urinalysis was performed, and the urine
sediment was evaluated using standard procedures.
Clinical condition, body temperature and body weight
were recorded at each sampling time point. M. hae-
mofelis-infected cats that developed severe anemia
(hematocrit < 10%) and/or were in a poor general con-
dition were treated with doxycycline orally (10 mg/
kg/d, Grünenthal GmbH, Mitlödi, Switzerland) for
14 days, prednisolone orally (2 mg/kg every 12 h,
gradually withdrawn, Streuli Pharma AG, Uznach,
Switzerland) for ten days and fluid therapy (Ringer’s
lactate solution, Fresenius Kabi (Schweiz) AG, Stans,
Switzerland) (see also Figure 1I).
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Figure 1 M. haemofelis loads, shedding patterns and hematocrit after M. haemofelis exposure in ten SPF cats. The five cats in group A
had undergone previous “Cand. M. turicensis” infection (A-E) and the five cats in group B were naïve control cats (F-J; the IDs for each cat are
indicated in the figure). The M. haemofelis exposure took place on day 0. The blood loads are presented as log DNA copy numbers per mL of
blood (left y-axis) as determined by real-time qPCR, and the hematocrit values are given as a percentage (right y-axis). The lower reference value
for the hematocrit is indicated by a dotted line. The PCR results from saliva, rectal swabs and urine are illustrated as triangles below the x-axes.
The PCR-positive swabs are indicated by filled symbols; PCR-negative swabs are indicated by open symbols. For clarity, only the first 90 days post
exposure are shown. The last urine sample listed under day 90 was collected on day 104. Cat JCT2 was treated with doxycycline (gray box marked
“D”) and prednisolone (white box marked “P”). The data from group B have been partially previously presented [19].
Baumann et al. Veterinary Research  (2015) 46:104 Page 3 of 16
Preparation of M. haemofelis inoculum and infection
procedure
The M. haemofelis low-dose infection model has been
previously described [19]. Briefly, heparinized infectious
blood from cat QLA5 [8] preserved in dimethylsulfoxide
(20%, vol/vol) in liquid nitrogen was used to prepare the
inoculum. The blood sample was thawed at 37° and di-
luted in cold phosphate-buffered saline (PBS) to a final
concentration of 1 × 103 copies in 100 μL as determined
by specific 16S rRNA TaqMan® real-time qPCR [14]. The
inoculum was maintained on ice. Each cat was subcuta-
neously injected with 100 μL of the inoculum in the
region of the neck within five minutes after dilution of
the inoculum.
Hematology and Coombs’ test
White blood cell differentials and complete hemograms
were performed using a Sysmex XT-2000iV (Sysmex
Corporation, Kobe, Japan) [23]. Hematocrit between
33% and 45% was considered within the reference range;
anemia was defined as a hematocrit value below 33%.
Leukopenia was defined as < 4.6 × 103/μL; and neutro-
penia was defined as < 2.3 × 103/μL. All hematological ref-
erence ranges were determined using identical methods
and blood samples from 63 clinically healthy cats. Because
a previous study demonstrated antibodies directed against
the erythrocyte surface in some M. haemofelis-infected
cats [24], Coombs’ test was performed. The Coombs’ test
was performed towards the end of the study on day 364
post M. haemofelis exposure as previously described [2],
with the following modifications: the feline anti-globulin
Coombs’ reagent (ImmunO™, MP Biomedicals, Solon,
Ohio, USA) was serially diluted from 1:2 to 1:10 240.
Clinical chemistry
Serum chemistry was performed using a Cobas Integra
800 system (Roche Diagnostics, Rotkreuz, Switzerland)
and included the laboratory’s standard feline clinical
chemistry panel: bilirubin, glucose, blood urea nitrogen
(BUN), creatinine, protein, albumin, cholesterol, trigly-
ceride, alkaline phosphatase, amylase, aspartate amino-
transferase, alanine aminotransferase, lipase, sodium,
chloride, potassium, calcium and phosphate. Globulin
values were calculated by subtraction of albumin from
the total protein concentration. Reference ranges are
stated as 5% and 95% quantiles and were determined for
routine purposes using identical methods and blood
samples from 59 clinically healthy cats.
Serum protein electrophoresis
Serum protein electrophoresis was performed on day 0
prior to and on days 44, 56/58 and 69 post M. haemofe-
lis exposure. A semi-automated agarose gel electrophor-
esis system (Hydragel-Hydrasis, Sebia PN 4100, Issy-les
Moulineaux, France) was used according to the manu-
facturer’s instructions (Hydragel 7 Protein kit, Sebia PN
4100). The reference ranges were determined for routine
purposes using identical methods and serum samples
from 59 clinically healthy cats and are stated as 5% and
95% quantiles.
Quantification of bacterial loads
Total nucleic acids (TNA) were extracted from 100 μL
of EDTA-anticoagulated blood using the MagNA Pure
LC Total Nucleic Acid Isolation Kit (Roche Diagnostic)
as previously described [2]. The saliva and rectal swabs
were incubated in PBS at 40 °C for 10 min prior to TNA
extraction as previously described [25]. TNA was
extracted from 100 μL of urine using the MagNA Pure
LC DNA Isolation Kit III (Bacteria, Fungi) (Roche Diag-
nostic). As pre-isolation steps, Bacterial lysis Buffer and
Proteinase K were added, and the mixture was incubated
at 65 °C for 10 min. The subsequent procedure was
performed according to the manufacturer’s instructions.
TNA was eluted into 100 μL of elution buffer and
stored at −20 °C until further use. During all nucleic acid
extractions, negative controls of 100 μL of PBS were
concurrently prepared with each batch of samples to
monitor cross-contamination.
All TNA samples were tested using TaqMan® real-time
qPCR for the presence and quantity of M. haemofelis
and “Cand. M. turicensis” on an ABI PRISM 7700/7500
Sequence Detection System (Applied Biosystems, Rotkreuz,
Switzerland) and a 10-fold serial dilution of plasmid stan-
dards as previously described [2,14]. For all PCR reactions,
positive (plasmid standard) and negative controls (nuclease
free water) were included in each assay.
Serology
Antibodies to M. haemofelis and “Cand. M. turicensis”
were measured using an ELISA based on recombinant
M. haemofelis DnaK protein as previously described [8]
and a serum dilution of 1:500. The signal-to-noise ratio
was calculated by dividing the post- by the pre-infection
absorbance values for each individual cat as previously
described [8]. An ELISA signal ratio of ≥1.5 was consid-
ered serologically positive [8]. Samples were collected up
to 371 days post M. haemofelis exposure and included in
the measurements.
Quantification of cytokine transcription levels
Blood samples for cytokine transcriptional analysis were
collected on days 0, 2, 6, 9, 13, 20, 27, 34 and 48 post M.
haemofelis exposure. One hundred microliters of EDTA-
anticoagulated blood was collected and immediately
mixed with 300 μL of mRNA lysis buffer (mRNA Isola-
tion Kit I, Roche Diagnostics). The samples were stored
at −80 °C within 1 h of collection. mRNA was purified
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using the mRNA Isolation Kit I and a MagNA Pure LC
instrument (Roche Diagnostics) according to the manu-
facturer’s instructions. mRNA was eluted into 25 μL of
elution buffer and stored at −80 °C until further use.
First-strand cDNA was synthesized using the High Cap-
acity cDNA Reverse Transcription Kit (Applied Biosys-
tems) according to the manufacturer’s instructions. For
each mRNA sample, the cDNA was synthesized in du-
plicate and pooled. The cDNA samples were stored at
−20 °C until use.
TaqMan® real-time PCR assays were performed for the
relative quantification of feline interferon-γ (IFN-γ),
interleukin (IL) 4, 6, 10 and 12 and tumor necrosis
factor-α (TNF-α) using primers and probes previously
described [26–28]. For IL-5, the primers fIL-5_121f
5’-TGAATAGGCTGGTGGCAGAGA-3’, fIL-5_194r:
5’-CAGGTTCCCGTCGCCTATC-3’ and the probe fIL-
5_143p: 5’-FAM-CTTGGCACTGCTCTCCACTCATCG
AACT-TAMRA-3’ were designed; the reverse primer an-
neals over an exon-exon junction. The IL-5 reaction con-
tained 0.9 μM forward and reverse primers and 0.25 μM
probe. All of the cytokine assays were run using TaqMan®
Fast Universal PCR Master Mix (2×) with an initial de-
naturation at 95 °C for 20 s followed by 45 cycles 95 °C for
3 s and 60 °C for 30 s. The transcription levels of the V-
abl Abelson murine leukemia viral oncogene homolog
(ABL) and zeta polypeptide (YWHAZ) genes served as
references for normalization as described [29]. These two
genes were found to be best for quantitative analysis in fe-
line blood samples [29]. PCR assays were performed using
a Rotor-Gene 6000 real-time rotary analyzer (Corbett,
Mortlake, Australia). The calculation of mRNA expression
levels from the Ct-values and the efficiencies of the cyto-
kine and reference gene assays was performed using GeN-
orm version 3.5 [30]. Briefly, the cytokine transcription
levels were normalized to the transcription levels of ABL
and YWHAZ at each time point and used to calculate the
relative transcription levels compared to day 0.
Flow cytometry analysis of lymphocyte subsets
EDTA-anticoagulated blood samples for flow cytometry
were collected on day 0 prior to M. haemofelis exposure
and on days 1, 2, 6, 9, 20, 27, 41, 57, 62, 76 and 83 after
M. haemofelis exposure and processed as previously de-
scribed [11]. The following antibody combinations were
used: 1) a fluorescein isothiocyanate (FITC)-conjugated
mouse anti-feline CD5 antibody (f43, Southern Biotech,
BioConcept, Allschwil, Switzerland) recognizing T lym-
phocytes [31] and an unconjugated mouse anti-feline
MHCII antibody (H34A, VMRD, Qiagen, Leipzig,
Germany); 2) an R-phycoerythrin (RPE)-conjugated
mouse anti-feline CD4 antibody (Vpg34, AbD Serotec,
Puchheim, Germany) and a fluorescein isothiocyanate
(FITC)-conjugated mouse anti-feline CD25 antibody
(kindly provided by M.B. Tompkins and G. Dean); 3) an
unconjugated mouse anti-feline CD8 antibody (FT2,
Southern Biotech) and a peridinin chlorophyll-a protein
(PerCP)-conjugated rat anti-mouse CD45R/B220 anti-
body (RA3-6B2, BD Bioscience, Allschwil, Switzerland).
Allophycocyanin (APC)-conjugated mouse IgG1 anti-
CD8 antibody (BD Bioscience) and an RPE-goat anti-
mouse IgG2b MHCII antibody (Southern Biotech) were
used as secondary antibodies. An aliquot of blood from
each cat was left unstained as a negative control. Flow
cytometry was performed using the BD FACSCalibur™
platform (BD Bioscience) and CellQuestPro™ software.
Forward and reverse scatter gates were set for the
lymphocyte population, and up to 10 000 events were
acquired for each sample. Each lymphocyte subset was
calculated as the product of the absolute lymphocyte
number (determined by hematology) and the subset per-
centage (determined by flow cytometry) as previously
described [32].
Statistics
The number of cats per experimental group was five;
it was kept to a minimum for animal welfare reasons.
At the same time, five animals per group are neces-
sary to potentially reach statistical significance be-
tween the groups; even if one cat or the results of
one cat per group are lost for unforeseeable reasons.
Statistical analyses were performed using Graph-Pad
Prism Version 3.0 (GraphPad Software, San Diego,
CA, USA) and nonparametric tests. Parameters were
compared between two groups using the Mann–Whit-
ney U-test (pMWU). The Wilcoxon signed-rank test
(pW) was used to compare the serum protein electro-
phoresis results from the same cat at two different
time points. Friedman’s test (pF) followed by Dunn’s
post test was used to analyze the parameters over
time when more than two time points were consid-
ered. Multiplicity adjusted p-values for each com-
parison in a family of comparisons were computed.
For the correlation analyses, the Spearman rank
correlation test was used (pS), and the correlation (r)
coefficient is given with the confidence interval (CI).
P-values < 0.05 were considered significant.
Results
No cross-protection against M. haemofelis and earlier
onset of infection in “Cand. M. turicensis”-recovered cats
At the start of the study, the blood from all ten cats was
PCR-negative for M. haemofelis and “Cand. M. turicen-
sis”. However, all cats became M. haemofelis PCR-
positive after subcutaneous M. haemofelis exposure, and
no cross-protection against M. haemofelis was observed
in cats previously infected with “Cand. M. turicensis”.
“Cand. M. turicensis” was not detectable by qPCR
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analysis of the blood samples from any of the cats. The
cats in group A became M. haemofelis PCR-positive be-
tween days 9 and 16 after exposure, while the naïve con-
trol cats in group B became PCR-positive between days
20 and 34 (Figure 1). Thus, cats that had experienced
“Cand. M. turicensis” infection became M. haemofelis
PCR-positive significantly earlier than the naïve cats
(pMWU = 0.008). The maximum M. haemofelis blood
loads were similar in both groups and reached >109 cop-
ies/mL of blood. The cats in group A displayed fairly
consistent high copy numbers (>107 copies/mL) starting
between days 21 and 31, which persisted until days 49 to
56 after M. haemofelis exposure. High bacterial loads
(>107 copies/mL) were observed later during infection
and less consistently in cats in group B (starting between
days 28 and 49 after exposure). Copy number fluctua-
tions throughout the course of M. haemofelis infection
were observed in all cats but were more pronounced in
the cats in group B; the copy number fluctuations were
particularly marked in cat ZKA2 in group B (up to a
four-log fluctuation within four days; Figure 1G).
Clinical signs of hemoplasmosis in naïve and “Cand. M.
turicensis”-recovered cats
Two cats in group A (FIA1, FIA2) and three cats in
group B (KCY2, ZKA2, JCT2) exhibited transient clinical
signs of hemoplasmosis within the first nine weeks after
subcutaneous exposure with M. haemofelis. The most
severe outcome was observed in cat JCT2 in group B
(Figure 1I); this cat was the last cat to become PCR-
positive in the present study. The severe clinical signs,
which necessitated antibiotic treatment, were described
previously [19]; briefly, the cat had an enlarged abdomen
and exhibited pale mucous membranes, apathy, anorexia
and increased salivation. The other four cats (cats FIA1,
FIA2, KCY2 and ZKA2) were depressed and exhibited
pale mucous membranes and a reduced appetite over a
period of a few days, but no treatment was required. No
significant deviations in body temperature or body
weight were observed in any cat during the course of the
experiment.
Early development of macrocytic hypochromic anemia
after M. haemofelis exposure in “Cand. M. turicensis”-
recovered cats
All five cats in group A and four of five cats in group B
developed anemia (hematocrit <33%) in the present
study (Figure 1). The cats in group A that previously
had undergone “Cand. M. turicensis” infection displayed
onset of anemia at 16 to 27 days post M. haemofelis expos-
ure (6 to 13 days after PCR-positivity at times of maximal
bacteremia in these cats), although one cat (FHT1) was
previously slightly and transiently anemic with a minimum
hematocrit of 30 on day 1 to 16 after exposure (Figure 1C).
Interestingly, in the four of five naïve cats in group B that
developed anemia, the onset of anemia occurred signifi-
cantly later than in the cats in group A (34 to 62 days post
M. haemofelis exposure; pMWU= 0.0159). The lowest single
hematocrit value among all cats was 13% (Figure 1I).
The cats in groups A and B exhibited significant
differences over time in hematocrit (Additional file
2A; marked by an asterisk) and RBC (data not
shown). The decreased red blood cell values coincided
with maximal bacteremia. Overall, the hematocrit was
significantly correlated with the M. haemofelis load
(pS < 0.0001; r = −0.46, CI −0.55 to −0.36).
The cats in group A also displayed significant differences
over time in erythrocyte volume (MCV; Additional file 2B)
and the hemoglobin concentration of the erythrocytes
(MCHC; Additional file 2C). The altered erythrocyte indi-
ces (increased MCV; decreased MCHC) coincided with
maximal bacteremia and anemia and were indicative of
macrocytic hypochromic anemia. The erythrocyte indices
returned to pre-exposure values more slowly than the
hematocrit (data not shown). The cats in group B exhibited
increased MCV and decreased MCHC similar to the cats
in group A but at slightly later time points (Additional files
2E and F). None of the cats tested positive in Coombs’ test
at the time point tested (late after infection; >300 days after
M. haemofelis exposure).
Decreased leukocytes, lymphocytes and eosinophils and
increased monocytes in “Cand. M. turicensis”-recovered
cats at times of maximal M. haemofelis bacteremia
The white blood cell (WBC) counts were not signifi-
cantly different between groups A and B at day 0.
Significant differences over time were observed in WBC
counts in the cats in group A but not in the cats in
group B (Figures 2A and E; low WBC counts in A
marked with an asterisk). However, all four anemic cats
in group B exhibited leukopenia at several time points
throughout the study. Neutropenia was observed in sev-
eral cats in both groups throughout the experiment but
occurred most frequently and more severely in cat JCT2,
which had to be treated due to severe clinical outcomes
(minimal neutrophil count: 1.0 × 103/μL on day 105). Re-
markably, the cats in group A had higher lymphocyte
counts than the naïve cats in group B at the start of the
experiment (days 0 to 6 and 9; pMWU = 0.0159; Figures 2B
and F). Significant differences over time in lymphocyte
counts were observed in group A (Figure 2B; decrease at
maximal bacteremia, marked with an asterisk). Due to
this decrease in lymphocyte counts in group A, there
was no difference between the two groups from days 16
to 41 post exposure; thereafter, the cats in group A had
higher lymphocyte counts than the cats in group B. In
addition and parallel to the decrease in WBC and
lymphocyte counts, a significant increase in monocyte
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a) e)
b) f)
c) g)
d) h)
Figure 2 Total leukocyte and leukocyte subset cell counts after M. haemofelis exposure in ten SPF cats. The five cats in group A had
undergone previous “Cand. M. turicensis” infection (A-D) and the five cats in group B were naïve control cats (E-H). The M. haemofelis exposure
took place on day 0. WBC (A, E), lymphocytes (B, F), monocytes (C, G) and eosinophils (D, H). Significant decreases and increases over time are
indicated with an asterisk, and durations spanning more than one time point are indicated as a solid black line (pF < 0.05 and pD < 0.05, unless
indicated otherwise). In detail, significant differences over time were observed in WBC counts in the cats in group A with decreased WBC counts
on days 20, 23, 30, 37 and 41 compared with days 65 and 109 post exposure (A). Significant differences over time were observed in lymphocyte
counts for both groups with decreased lymphocyte counts on days 20, 23, 27 and 37 compared with days 62, 19, 83, 90, 105 and 141 post
exposure in cats in group A (B) (no significance in the post test for group B; F). A significant increase in monocyte counts with increased values
on days 20 to 48 compared with days 141, 190, 232, 272 and 371 post exposure (C) and a decrease in eosinophil counts with decreased values
on days 30, 37, 41, 48 and 57 compared with day 9 and day 286 after M. haemofelis exposure were observed in the cats in group A (D). In group
B an increase in monocytes with increased values on day 34 compared with days 105, 141, 190 and 371 post exposure (G) and a decrease in
eosinophils were found decrease on day 57 compared with day 190 post exposure (H). Upper and lower reference values are indicated as a
dotted line.
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counts (Figure 2C) and a decrease in eosinophil counts
(Figure 2D) were observed in the cats in group A. In
group B similar alterations but less pronounced were ob-
served; these included increased monocytes (Figure 2G)
and decreased eosinophils (Figure 2H).
Early increase in T cells and decrease in several
lymphocyte subsets at times of high bacteremia in M.
haemofelis-exposed “Cand. M. turicensis”-recovered cats
Although the cats in group A had higher total lympho-
cyte counts on day 0, no significant differences in
lymphocyte subsets were observed at that time point
(Figure 3). However, the cats in group A had signifi-
cantly higher T cell counts, CD4+ and CD8+ T lympho-
cyte counts, activated CD4+ T cell (CD4+CD25+) and B
cell counts than the cats in group B at several time
points throughout the study: T cells, CD4+ and CD8+
cells were higher in group A than in group B already
within days after M. haemofelis exposure, while B cells
were significantly higher in group A compared to group
B later during the course of infection after maximal
bacteremia (Figure 3A, B, C and E; all differences
marked by asterisks). Significant differences over time
were observed in T cell counts in both groups with in-
creased values in group A within days after M. haemofe-
lis exposure (Figure 3A; marked by arrows). In addition,
cats in group B exhibited significant differences over
time in activated CD4+ T cell (CD4+CD25+) counts also
within days after M. haemofelis exposure (Figure 3E;
marked by arrows). Significantly decreased CD8+ T
lymphocyte counts were observed in group A at the on-
set of maximal bacteremia (day 20) compared with later
time points (Figure 3C; marked by arrows), while B cells
were decreased at times of maximal bacteremia in group
A (days 20 to 41) and rebounded thereafter (Figure 3F;
marked by arrows). Finally, the CD4+/CD8+ ratio
significantly fluctuated over time, but no clear pattern
was recognized (Figure 3D).
Serum proteome in “Cand. M. turicensis”-recovered cats:
polyclonal hypergammaglobulinemia at maximal
bacteremia
When comparing the two groups, the cats in group A
had significantly higher protein, albumin and globulin
concentrations than the cats in group B prior to M.
haemofelis exposure (day 0, pMWU < 0.05; Figure 4A
and Additional files 3A to C). The cats in group A
exhibited a significant increase in total serum protein
and globulin and a decrease in albumin particularly at
3 to 8 weeks after M. haemofelis exposure, consistent
with maximal bacteremia in these cats (Additional
files 3A to C). The cats in group B exhibited ten-
dencies that were similar but less pronounced than
those of group A (Additional files 3F to H). Globulin
concentrations were significantly higher in group A
than group B on days 23, 30 and 37, and the albumin
concentration was lower on day 37 post exposure
(pMWU < 0.05; Additional file 3).
Serum protein electrophoresis prior to M. haemofelis
exposure revealed that the cats in group A had signifi-
cantly higher ɑ2-, β- and ɣ-globulin values than the cats in
group B (pMWU < 0.05; Figure 4B). Significant differences
over time were observed when all ten cats were analyzed
in combination (Figure 4C and D). Albumin concentra-
tions were significantly lower and ɣ-globulin concentrations
significantly higher at the tested time points after M. haemo-
felis exposure compared to pre-exposure values (Figure 4D;
Additional files 3B and G). Nine of the ten cats had ɣ-
globulin concentrations above the reference range (>16 g/
L) at days 44, 56/58 or 69 (Figure 4D and data not shown).
The albumin to globulin ratio was significantly de-
creased at all three tested time points after M. hae-
mofelis exposure compared with pre-exposure values
(pW ≤ 0.0137; data not shown). Moreover, on day 44
after M. haemofelis exposure, the β-globulin fraction
was significantly higher compared with the pre-
exposure values (PW ≤ 0.0091; data not shown). The
electrophoretogram on day 44 post exposure indicated
polyclonal hypergammaglobulinemia (Figure 4F).
Increases or decreases in other clinical chemistry
parameters at maximal M. haemofelis bacteremia
The cats in group A, and in group B albeit less
pronounced, exhibited significant differences over time in
additional clinical chemistry parameters throughout the
experiment. Mostly 3 to 8 weeks after M. haemofelis
exposure, consistent with maximal bacteremia, the fol-
lowing deviations were observed: decreased cholesterol
(Additional files 3D and I), creatinine (Additional files
3E and K), alkaline phosphatase (Additional files 4A
and D), sodium (Additional files 4C and F) and
increased bilirubin (Additional files 4B and E). A sig-
nificant inverse correlation was observed between the
bilirubin concentration and the hematocrit values (pS
< 0.0001; r = −0.30, CI −0.45 to −0.15).
Increase in anti-DnaK antibodies in “Cand. M. turicensis”-
recovered cats after M. haemofelis exposure
The cats in group A that had previously experienced
“Cand. M. turicensis” infection were serologically positive
at the beginning of the study (Additional file 1A). These
cats displayed a remarkable increase in antibody levels on
days 13 to 23 post exposure (PW = 0.0625) and had sig-
nificantly higher antibody levels than the cats in group
B from day 0 to 41 after exposure (pMWU ≤ 0.0317;
Additional file 1). The five naïve cats in group B were
seronegative at the start of the study (ELISA signal-to-
noise ratio <1.5; Additional file 1B). The cats
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seroconverted seven to ten days after the blood samples
were identified as PCR-positive and 30 to 37 days after
exposure, with the exception of cat JCT2, which sero-
converted 55 days after M. haemofelis exposure. For
JCT2, seroconversion occurred 21 days after the cat
had been transiently identified as PCR-positive and ten
days after the onset of persistent PCR-positivity. The
cats in group A achieved maximum antibody production
significantly earlier during acute infection (20 to
30 days post exposure) than the cats in group B (37
to 62 days post exposure; pMWU = 0.0079), and the
maximum antibody levels during acute infection were
significantly higher in group A (19.0 – 30.3) than in
group B (10.7 – 17.6; pMWU = 0.0079). The antibody levels
were significantly correlated with the M. haemofelis blood
load (pS < 0.0001; r = 0.57, CI 0.48 to 0.65).
Cytokine transcription levels: predominance of the Th1
response at maximal M. haemofelis bacteremia
Similar patterns of cytokine transcription levels were ob-
served in groups A and B, with a tendency of alterations
occurring later in group B than in group A (Figure 5).
IFN-γ (Th1) and IL-10 (anti-inflammatory) mRNA levels
varied significantly over time in both groups with higher
values at times of maximal bacteremia compared to
values early after M. haemofelis exposure (Figures 5A
and C; indicated by arrows). The increase in mean IFN-γ
transcription levels was more pronounced in group A
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Figure 3 Lymphocyte subsets after M. haemofelis exposure in the ten SPF cats. The five cats in group A had undergone previous “Cand.
M. turicensis” infection and the five cats in group B were naïve control cats. The M. haemofelis exposure took place on day 0. A) T cells
(CD5 + MHCII+ ) counts, B) CD4+ T cell counts, C) CD8+ T cell counts, D) CD4+/CD8+ ratio, E) CD4+CD25+ activated T cells counts and F) B
cell (CD45R/B220+) counts. No significant differences between groups A and B were observed on day 0; significant differences between the
two groups observed thereafter are indicated with an asterisk (pMWU < 0.05). Significant differences over time (pF < 0.05 and pD < 0.05) and the
corresponding significantly decreased or increased values are indicated with an arrow (black solid for group A and gray open for group B).
In detail, increased T cell counts were observed in group A on days 2, 6 and 62 compared with day 83 and in group B on day 9 and 20
compared with day 83 (A). Decreased CD8+ T lymphocyte counts were observed in group A on day 20 compared with days 57 and 83 (C).
In the CD4+/CD8+ ratio, in group A, significantly lower values were observed on day 48 compared to days 0 and 41, whereas in group B,
higher counts were observed on day 0 compared to days 9 and 83 and on and 41 compared to day 9 (D). CD4+CD25+ cell counts varied
significantly over time in cats in group B, with lower values on days 2, 9 and 27 compared with day 6 (E). B cells varied significantly over time
in cats in group A, with transiently decreased values on days 20, 27, 34 and 41 compared with days 9, 62, 76 and 83 (F). No values were
available for CD4+CD25+ on day 83.
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(day 2 to day 20: ~1100-fold increase) than in group B
(day 2 to 34: ~20-fold increase), while the increase in IL-
10 mean transcription levels was more pronounced in
group B (day 2 to day 34: ~1700-fold increase) than in
group A (day 2 to 27: ~50-fold increase). Moreover, a
significant decrease in IL-4 (Th2) levels was observed in
group B (Figure 5D). A significant decrease over time of
the IL-4/IFN-γ ratio (Th2/Th1) particularly in group A
(day 2 to day 27 post exposure: mean decrease ~250-
fold) and of the IL-4/IL-12 ratio (Th2/Th1) ratio par-
ticularly in group B were observed (Figure 5G and H). In
contrast, TNF-α mRNA levels significantly increased
over time in both groups (Figure 5I). No significant dif-
ferences over time were observed in IL-5, IL-6 and IL-12
transcription levels (Figures 5E, F and B). No significant
differences were observed between groups A and B
except for a difference in the IL-4/IL-12 at day 20
(Figure 5I; marked by an asterisk).
Detection of low-level M. haemofelis shedding in saliva,
feces and urine samples
Saliva and rectal swabs were collected at the time points
indicated in Figure 1 and on days 141, 232 and 286 post
M. haemofelis exposure. Some rectal swabs for all cats
and some saliva swabs for eight of ten cats were PCR-
positive for M. haemofelis. For two cats in group B
(KCY2 and KCU1), all tested saliva swabs were negative
(Figures 1F and J). The M. haemofelis loads in saliva and
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Figure 4 Serum protein electrophoresis results. A and B: pre-exposure values of total protein concentrations (A) and globulins (B) in the cats
of groups A (black triangles) and B (open circles). C and D: comparison of the pre-exposure values (day 0; open squares) to those obtained on
day 44 post M. haemofelis exposure (black squares). In A through D, the horizontal line indicates the median. P-values (A and B: pMWU, C and D:
pW) are indicated in the figure. E and F: representative results for serum protein electrophoresis (of cat FIA1, group A) before (E) and at 44 days
post M. haemofelis exposure (F). Albumin concentrations were significantly lower and ɣ-globulin concentrations were significantly higher on day
44 after M. haemofelis exposure compared with the pre-exposure values (D; pW < 0.05). The electrophoretogram conducted with a sample col-
lected on day 44 (F) illustrates polyclonal hypergammaglobulinemia with a ɣ-globulin concentration of 40.2 g/L (reference range: 5.7-16.0 g/L).
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feces were between 200 to 780 copies/swab. Most of the
positive results were obtained during high bacteremia.
All saliva and rectal swabs collected on days 141, 232
and 286 post M. haemofelis exposure tested M. haemofe-
lis PCR-negative (data not shown).
The urine samples for nine of ten cats tested PCR-
positive for M. haemofelis; cat FIA2 in group A was
negative on all four occasions tested (Figure 1B). The M.
haemofelis loads in the urine samples were 2 × 102 to
1.4 × 105 copies/mL of urine. The highest M. haemofelis
load in urine was observed in a sample with high
erythrocyte contamination in urinalysis. Shedding in
urine was not strictly associated with high blood loads
(no significant correlation between blood and urine
loads was observed, pS > 0.05) or blood contamination of
the urine sample (data not shown).
Long-term outcome of M. haemofelis infection: recovery
in the absence of antibiotic treatment
Remarkably, five cats became PCR-negative for the de-
tection of M. haemofelis in the blood within the observa-
tion period without antibiotic treatment: four cats in
group A (cat FIA1, FIA2, FHX4 and FHX5) and one cat
in group B (KCY2). The remaining six cats were still
PCR-positive at the end of the study, 371 days after M.
haemofelis exposure (data not shown).
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Figure 5 Transcription levels of cytokines after M. haemofelis exposure in the ten SPF cats. The five cats in group A had undergone previous
“Cand. M. turicensis” infection and the five cats in group B were naïve control cats. The M. haemofelis exposure took place on day 0. A) IFN-γ, B)
IL-12, C) IL-10, D) IL-4, E) IL-5, F) IL-6, G) IL4/IFN-γ ratio, H) IL-4/IL-12 ratio and I) TNF-α. Y-axis: relative transcription levels (log scale). Significant differ-
ences over time (pF < 0.05 and pD < 0.05) and the corresponding significantly decreased or increased values are indicated with an arrow (black solid for
group A and gray open for group B). In detail, IFN-γ mRNA levels varied over time, with higher values on days 20 and 27 compared with days 2 and 9
in group A and on day 34 compared with days 2 and 13 in group B (A). IL-10 mRNA levels increased throughout the study, with higher levels on day
27 compared with days 2, 6, and 9 in group A and higher levels on day 34 compared with days 2, 6 and 13 in group B (C). IL-4 levels varied over time
in both groups with lower IL-4 levels on day 48 compared with day 13 in group B (post test not significant for group A; D). The IL-4/IFN-γ ratio
varied in both groups over time, with a decreased in group A from day 2 to 27 (post test not significant for group B; G). The IL-4/IL-12 ratio
varied over time in both groups, with a decrease from days 20 to 48 in group B, and lower levels in group A compared with group B on day
20 (H). TNF-α mRNA levels varied over time in both groups, with higher levels observed on days 27, 34 and 48 compared with day 2 in group
B (post test not significant for group A; I).
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Discussion
In the present study, no cross-protection against M. hae-
mofelis was observed in any of the five “Cand. M. turi-
censis”-recovered cats. By contrast, cats previously
infected with “Cand. M. turicensis” infection exhibited
faster onset of the infection and became PCR-positive
and anemic significantly earlier than the naïve M. haemo-
felis-exposed control cats. Moreover, the cats previously
infected with “Cand. M. turicensis” had persistently high
M. haemofelis bacterial loads (≥107 copies/mL) and higher
total, CD4+, CD8+ and CD4+CD25+ T cells than naïve
cats within days after M. haemofelis exposure. There are
several possible explanations for the finding that “Cand.
M. turicensis”-recovered cats became M. haemofelis PCR-
positive significantly earlier than naïve cats. Pre-existing
antibodies against hemoplasmas might have impacted the
kinetics of M. haemofelis infection in cats that had recov-
ered from “Cand. M. turicensis” infection, e.g., through
antibody-dependent enhancement (ADE). ADE can in-
crease the replication and distribution of pathogens, par-
ticularly viruses, e.g., feline corona virus [33]. However,
ADE has also been suspected in bacterial infection [34]
because the specific antibody response against Streptococ-
cus pneumoniae enhances infection. It has been specu-
lated that bacterial enzymes can modify specific IgA1
antibodies so that the binding of bacteria to the target
cells is not inhibited but augmented, thereby facilitating
the prolonged persistence of the bacteria at the mucosal
surfaces of the respiratory tract [34,35]. Because cross-
reactivity of antibodies to feline hemoplasmas, at least to
the currently available recombinant M. haemofelis antigen
DnaK, has been demonstrated [8,9], the occurrence of a
similar phenomenon in “Cand. M. turicensis”-recovered
cats with high antibody levels prior to M. haemofelis
exposure cannot be excluded. Alternatively, chronically
“Cand. M. turicensis”-infected cats may have become M.
haemofelis PCR-positive earlier than naïve cats due to
modulation or down-regulation of the immune system.
The influence of a hemotropic mycoplasma infection on
the host immune system has not yet been completely
elucidated. For non-hemotropic mycoplasma infections, a
multitude of mechanisms have been described that might
modulate or down-regulate the cell-mediated and/or
humoral immune response of the infected host [36].
None of these hypotheses, however, can adequately
explain the observed enhancement after heterologous
(“Cand. M. turicensis”-M. haemofelis) but not homolo-
gous challenge (“Cand. M. turicensis”-“Cand. M. turi-
censis” and M. haemofelis-M. haemofelis) [10,12,11].
Based on the immune response after hemoplasma infec-
tions, a Th1 response was suspected in primary M. hae-
mofelis infection in naïve cats [12], while primary “Cand.
M. turicensis” infection in naïve cats might be associated
with an early Th1 response, with a subsequent switch to
Th2 [11]. In cats that had recovered from “Cand. M. tur-
icensis” infection, protection from reinfection was asso-
ciated with an early and pronounced Th2 response [11].
While these results require further confirmation, the
Th1/Th2 response may have at least partially contrib-
uted to the lack of cross-protection and the differences
in the infection kinetics observed in the present study. If
indeed “Cand. M. turicensis” infection leads to the
stimulation of the humoral immune response (Th2), this
effect might be counterproductive during subsequent M.
haemofelis exposure, in which protection was observed
in the absence of a Th2 response [12]. At the start of the
study, in addition to the seropositivity for DnaK, “Cand.
M. turicensis”-recovered cats had higher total lympho-
cyte counts, protein, albumin and ɑ2-, β- and ɣ-globulin
concentrations than the naïve control cats, indicating
immune system stimulation in “Cand. M. turicensis”-re-
covered cats. In particular, the increase in globulin levels
may indicate a predominance of the humoral immune
response in these cats. Thus, the “Cand. M. turicensis”-
recovered cats, despite or even due to the observed sero-
positivity and the status of the immune system, may
have been ill-prepared for subsequent M. haemofelis ex-
posure. Consistently, within days after M. haemofelis ex-
posure, “Cand. M. turicensis”-recovered cats exhibited
higher total, CD4+, CD8+ and reactivated (CD4+CD25+)
T-cell counts than the control cats.
Particularly in lymphocytes and lymphocyte subsets,
differences were observed between the naïve cats and
the “Cand. M. turicensis”-recovered cats in that “Cand.
M. turicensis”-recovered cats but not naïve cats showed
a transient decrease in lymphocyte subsets, especially in
B cells, during maximal bacteremia. In a previous study,
a transient decrease in lymphocytes during M. haemofelis
infection was attributed to cell migration from the blood
to the draining lymph nodes, where lymphocytes become
activated and proliferative [12]. The increase in total pro-
tein concentrations suggests B cell activation during high
bacteremia. This increase was paralleled by a decrease in
albumin, possibly due to the role of albumin as a negative
acute phase protein [37]. The increase in total protein at
the time of maximal bacteremia is primarily attributable
to the increased production of immunoglobulins, as dem-
onstrated by the detection of polyclonal hypergammaglo-
bulinemia in the serum protein electrophoresis of samples
obtained from nine of ten cats. While the observed hyper-
gammaglobulinemia coincided with the high specific anti-
bodies to M. haemofelis determined by recombinant M.
haemofelis DnaK antigen ELISA, a large proportion of the
immunoglobulins were probably not hemoplasma-
specific, reflecting polyclonal B cell activation. Mitogenic-
ity and the activation of lymphocytes in a non-specific
polyclonal manner has been well described for non-
hemotropic mycoplasmas [36]. For Mycoplasma suis, a
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porcine hemoplasma, significant alterations to the RBC
surfaces lead to the upregulation of naturally occurring B
cells specific for self-antigens and the induction of auto-
reactive IgM and IgG, which in turn leads to extra and
intravascular hemolysis [38]. A previous study demon-
strated that M. haemofelis-infected cats harbor anti-
bodies directed against the erythrocyte surface
(Coombs’ test positive) at the nadir of hematocrit
values and at times of maximal bacteremia [24]. In the
current study, Coombs’ test was negative, but this test
was performed at a later time point during infection,
when B cell counts and immunoglobulin values had
returned to pre-infection values.
Several alterations in clinical chemistry parameters as-
sociated with high M. haemofelis blood loads were ob-
served, such as decreased cholesterol. Alterations in
lipid metabolism and decreased cholesterol levels have
been reported in many infections, including viral, bacter-
ial and parasitic infections [39,40]. The observed de-
crease in cholesterol concentration in the present study
might reflect an increased need for cholesterol for mem-
brane synthesis for either large numbers of RBCs
destroyed during the M. haemofelis infection and/or the
fast amplification of hemoplasmas. Mycoplasmas depend
on cholesterol from the host for membrane synthesis
and they incorporate large quantities of cholesterol into
the membrane for improved membrane fluidity [36].
Moreover, a significant increase in bilirubin concentra-
tion was observed at some time points. As previously
described [1], acute M. haemofelis infection may lead to
hemolytic anemia, resulting in an increase in the biliru-
bin concentration. In the present study, the bilirubin
concentration was directly associated with the bacterial
loads, which may be supportive of a causal connection.
The cytokine response observed during M. haemofelis
infection in the present study was predominantly of the
Th1 type, consistent with previous results for naïve cats
infected with M. haemofelis [12]. In the present study,
naïve but particularly “Cand. M. turicensis”-recovered
cats displayed a massive (~1100-fold) increase in IFN-γ
transcription levels approximately coincident with the
appearance of high bacterial loads. This effect was paral-
leled by a pronounced decrease in the IL-4/IFN-γ ratio
(~250-fold). These alterations suggest the predominance
of a Th1 response in both groups after the establishment
of high bacterial loads in these cats, in contrast to the
predominance of a Th2 response with high IL-4 tran-
scription levels, a high IL-4/IL-12 ratio and an increase
in eosinophils observed in “Cand. M. turicensis”-infected
cats during high “Cand. M. turicensis” bacteremia [11].
Consistent with the absence of a Th2 response, no eo-
sinophilia was observed in the present study; rather, a
decrease in eosinophils was observed at times of max-
imal bacteremia. The Th1 response postulated in the M.
haemofelis-infected cats in the present study might at
first glance be contradicted by the major increase in IL-
10 levels particularly in naïve cats (~1700-fold) also ob-
served during high bacterial loads. An increase in IL-10
transcription levels was also observed in a previous
study in naïve cats infected with M. haemofelis but not
in cats protected from M. haemofelis re-infection [12].
IL-10 has multiple effects [41]: it inhibits Th1 cells and
may be associated with B cell proliferation and antibody
production. Thus, the high IL-10 transcription levels ob-
served at times of high bacteremia would be consistent
with the high serum protein, γ-globulin and anti-M. hae-
mofelis DnaK antibody levels observed at the same time.
However, IL-10 is also considered a potent anti-
inflammatory cytokine that may limit the damage to the
host due to exacerbated inflammation while prolonging
pathogen clearance [41,42]. Therefore, it has been hy-
pothesized that the high IL-10 levels observed during
maximal bacteremia in M. haemofelis-infected cats in a
previous study might limit the inflammatory response to
M. haemofelis and potentially prevent the clearance of
these organisms [12]. Whether such an anti-inflammatory
effect is beneficial during bacterial infections and sepsis
has been debated. It is unknown if high (anti-inflamma-
tory) IL-10 levels observed in the present study are
associated with the decreased leukocyte counts and
neutropenia observed during high bacteremia; among
other hematological alterations, leukocytosis and neutro-
philia are characteristics of inflammation. A reduction in
local and systemic inflammation in connection with IL-10
may reflect the inhibition of cell trafficking, particularly the
recruitment of neutrophils to the injury site, via inhibition
of the production of neutrophil chemoattractants [42].
When measuring antibodies to M. haemofelis, “Cand.
M. turicensis”-recovered cats displayed an earlier and
higher increase in anti-DnaK antibodies than naïve cats.
By contrast, no increase in antibodies was observed in
cats protected from homologous reinfection [12,11]; in-
deed, in cats that had undergone “Cand. M. turicensis”
infection, a transient decrease in antibodies was ob-
served upon homologous “Cand. M. turicensis” re-
exposure, potentially reflecting the binding of antibodies
to the inoculated antigens [10,11]. The levels of anti-
bodies observed in the present study in response to M.
haemofelis infection were higher than the level of anti-
bodies reported in “Cand. M. turicensis” infection [10],
consistent with the results of previous studies using a
similar preparation of the same antigen [9]. This finding
might reflect the higher blood loads obtained after M.
haemofelis exposure compared with “Cand. M. turicen-
sis” and the use of DnaK of M. haemofelis and not
“Cand. M. turicensis” as the antigen for ELISA [8].
The shedding patterns of M. haemofelis were also in-
vestigated in the present study. This study is the first to
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report shedding of M. haemofelis DNA in saliva, feces
and urine. Positive saliva and rectal swabs were obtained
during high bacteremia, but only infrequently and not
persistently. This finding might explain why previous
studies were unable to detect M. haemofelis in saliva and
salivary gland samples collected at only one time point
or late during infection in only a few cats [22,43]. More-
over, the M. haemofelis loads observed in salivary swabs
(a few hundred copies/swab) in the present study corre-
sponded to those of “Cand. M. turicensis”-infected cats,
as reported in previous studies [21,22]. Because “Cand.
M. turicensis”-infected cats fairly consistently shed
“Cand. M. turicensis” via saliva during high bacteremia
[21,22] but the maximal blood loads were lower than in
M. haemofelis-infected cats, factors other than blood
load must play a role in whether feline hemoplasmas are
shed via saliva. No M. haemofelis transmission studies
using PCR-positive saliva or feces have been conducted.
Transmission studies have been performed using “Cand.
M. turicensis” PCR-positive saliva, but naïve cats did not
demonstrate infection after oral uptake or subcutaneous
inoculation of “Cand. M. turicensis” PCR-positive saliva
[21]. In the present study, M. haemofelis-positive urine
samples were also observed. Because the samples were
collected through cystocentesis, we cannot completely
exclude a contribution of erythrocyte contamination to
the PCR-positive result. However, M. haemofelis PCR-
positive results were also detected in urine samples in
which no erythrocytes were detectable using urine test
strips and sediment analyses. The low M. haemofelis
copy numbers in the saliva, feces and urine samples of
M. haemofelis-infected cats and the infrequent shedding,
even during high bacteremia, suggest a minimal risk of
transmission through mutual grooming and the sharing
of feeding dishes or litter boxes; however, this should be
confirmed in future studies.
In conclusion, in contrast to homologous challenge,
no protection against heterologous M. haemofelis
challenge was observed in cats that had recovered
from a previous “Cand. M. turicensis” infection, indi-
cating that “Cand. M. turicensis” is probably not a
good candidate for an attenuated vaccine against the
more pathogenic M. haemofelis. The differences in
the immune reaction patterns (Th1 versus Th2) after
“Cand. M. turicensis” and M. haemofelis infections
were further corroborated. The study provides the
first evidence of the presence of polyclonal hypergam-
maglobulinemia in cats infected with feline hemoplas-
mas. Moreover, recovered cats had higher lymphocyte
counts. Finally, the study also suggests that a previous
hemoplasma infection, even when the cat has osten-
sibly recovered, may influence subsequent infections
and potentially lead to an enhancement phenomenon
or differences in infection kinetics.
Additional files
Additional file 1: Antibody response to DnaK after M. haemofelis
exposure in ten SPF cats. The five cats in group A had undergone
previous “Cand. M. turicensis” infection (A) and the five cats in group B
were naïve control cats (B). The M. haemofelis exposure took place on
day 0. The antibody levels are presented as the signal-to-noise ratio
determined by M. haemofelis rDnaK ELISA. A signal-to-noise ratio ≥1.5
(indicated by a dotted line) was defined as positive [8]. The cats in group
A had significantly higher antibody levels than the cats in group B from
days 0 to 41 (indicated by a line and an asterisk). The data from group B
have been partially previously presented [19].
Additional file 2: Red cell parameters after M. haemofelis exposure
in the ten SPF cats. The five cats in group A had undergone previous
“Cand. M. turicensis” infection (A-C) and the five cats in group B were
naïve control cats (D-F). The M. haemofelis exposure took place on day 0.
Hematocrit (A, D), mean corpuscular volume (MCV; B, E) and mean
corpuscular hemoglobin concentration (MCHC, (C, F). Significant
decreases and increases over time are indicated with an asterisk, and
durations spanning more than one time point are indicated as a solid
black line. The cats in group A exhibited significant differences over time
in the hematocrit (pF < 0.0001; decreased values on days 27, 30, 34, 37, 41
and 48 compared with days 0, 83, 90 and 141: pD < 0.05; A) and RBC
counts (pF < 0.0001; decreased values on days 27 to 48 compared with
pre-exposure and days 83, 90 and 141 after exposure: pD < 0.05; data not
shown). Similar alterations were observed in cats in group B (hematocrit:
pF ≤ 0.0005; decreased values on day 62 compared with days 141 and
280: pD < 0.05, D; RBC: pF < 0.0001; decreased values on day 69 and 105
compared with day 141: pD < 0.05; data not shown). The cats in group A
displayed also significant difference over time in MCV (pF < 0.0001;
increased values on days 27, 34, 37, 41, 48 and 57 compared with day 2
and days 190, 232 and 272 post exposure: pD < 0.05; B) and the
hemoglobin concentration of the erythrocytes (MCHC) (pF < 0.0001;
decreased values on days 27, 30 and 41 compared with day 2 and days
190, 232, 371 post exposure: pD < 0.05; C). The cats in group B exhibited
alterations similar to those in group A but at slightly later time points (MCV
and MCHC: pF < 0.0001; no significance in the post tests; E and F). Upper
and lower reference values are indicated as a dotted line.
Additional file 3: Selected clinical chemistry parameters after M.
haemofelis exposure in the ten SPF cats I. The five cats in group A
had undergone previous “Cand. M. turicensis” infection (A-E) and the
five cats in group B were naïve control cats (F-J). The M. haemofelis
exposure took place on day 0. Total protein (A, F), albumin (B, G),
globulin (C, H), cholesterol (D, I), and creatinine (E, K). The cats in
group A had significantly higher protein, albumin and globulin
concentrations at the beginning of the experiment than the cats in
group B (pMWU < 0.05; A to C and F to H). Significant increases and
decreases over time are indicated with an asterisk, and durations
spanning more than one time point are indicated as a solid black
line. The cats in group A exhibited significant alterations over time in
total serum protein (pF < 0.0001; increased values on days 30 and 44
compared with days 16, 232 and 286: pD < 0.05, A), albumin (pF < 0.0001;
decreased values on days 30, 37, 44 and 57 compared with days 0, 286 and
328: pD < 0.005, B) and globulin (pF < 0.0001; increased values on days 30, 37
and 44 compared with days 16, 232, 286 and 371: pD < 0.005, C). The cats in
group B exhibited similar but less pronounced alterations than the cats in
group A in total protein (pF < 0.0001; increased values on day 69 compared
with days 0 and 23: pD < 0.05; F), albumin (pF < 0.0001; decreased values on
day 57 compared with days 232, 328 and 371: pD < 005; G) and globulin
(pF = 0.0015; increased values on day 69 compared with day 0: pD < 0.005;
H). Moreover, the cats in group A also exhibited significant alterations over
time in: cholesterol (pF < 0.0001; decreased values on days 30, 37, 44 and 57
compared with days 0, 190, 272, 286 and 328: pD < 0.05; D) and creatinine
(pF < 0.0001; decreased values on days 30, 57 and 69 compared with days
141 and 328: pD < 0.05; E). Similarly, the cats in group B exhibited differences
over time in: cholesterol (pF < 0.0001; decreased values on days 37, 44, 57
and 83 compared with days 9, 328 and 371: pD < 0.05; I) and
creatinine (pF < 0.0001; decreased values on days 30, 57 and 69
compared with days 0 and 141: pD < 0.05; K). Upper and lower
reference values are indicated as a dotted line.
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Additional file 4: Selected clinical chemistry parameters after M.
haemofelis exposure in the ten SPF cats II. The five cats in group A
had undergone previous “Cand. M. turicensis” infection (A-C) and the five
cats in group B were naïve control cats (D-F). The M. haemofelis exposure
took place on day 0. Alkaline phosphatase (A, C), bilirubin (B, E) and
sodium (C,F). Significant increases and decreases over time are indicated
with an asterisk, and durations spanning more than one time point are
indicated as a solid black line. The cats in group A exhibited significant
differences over time in: alkaline phosphatase (pF < 0.0001; decreased
values on days 23, 30, 37 and 44 compared with days 286, 328 and 371:
pD < 0.05; A), bilirubin (pF = 0.0001; increased values on days 37 and 141
compared with day 328: pD < 0.05; B) and sodium (pF = 0.0001; decreased
values on days 37, 57, and 69 compared with days 0, 328 and 371: pD < 0.05;
C). Similarly, the cats in group B exhibited significant alterations over time in:
alkaline phosphatase (pF = 0.0005; no significance in the post test; D), bilirubin
(pF = 0.0387; no significance in the post test; E) and sodium (pF = 0.0001;
decreased values on days 57 and 83 compared with days 328 and
371: pD < 0.05; F). Bilirubin concentrations were higher in group A
than in group B 30 days after M. haemofelis exposure (pMWU < 0.05; B,
E). Upper and lower reference values are indicated as a dotted line.
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